A Conserved Di-Lysine Motif in the E2 Transactivation Domain Regulates MmuPV1 Replication and Disease Progression

Overview

Journal Pathogens

Date 2025 Jan 25

PMID 39861045

Authors

Jessica Gonzalez

Marsha DeSmet

Elliot J Androphy

Affiliations

Soon will be listed here.

Abstract

The papillomavirus E2 protein regulates the transcription, replication, and segregation of viral episomes within the host cell. A multitude of post-translational modifications have been identified which control E2 functions. A highly conserved di-lysine motif within the transactivation domain (TAD) has been shown to regulate the normal functions of the E2 proteins of BPV-1, SfPV1, HPV-16, and HPV-31. This motif is similarly conserved in the E2 of the murine papillomavirus, MmuPV1. Using site-directed mutagenesis, we show that the first lysine (K) residue within the motif, K112, is absolutely required for E2-mediated transcription and transient replication in vitro. Furthermore, mutation of the second lysine residue, K113, to the potential acetyl-lysine mimic glutamine (Q) abrogated E2 transcription and decreased transient replication in vitro, while the acetylation defective arginine (R) mutant remained functional. Both K113 mutants were able to induce wart formation in vivo, though disease progression appeared to be delayed in the K113Q group. These findings suggest that acetylation of K113 may act as a mechanism for repressing MmuPV1 E2 activity.

References

Gonzalez J, Stoll K, DeSmet M, Androphy E . A conserved cysteine in the DNA-binding domain of MmuPV1 E2 is required for replication . J Virol. 2024; 99(1):e0142324. PMC: 11784461. DOI: 10.1128/jvi.01423-24. View

Schweiger M, You J, Howley P . Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol. 2006; 80(9):4276-85. PMC: 1472042. DOI: 10.1128/JVI.80.9.4276-4285.2006. View

Doorbar J . The papillomavirus life cycle. J Clin Virol. 2005; 32 Suppl 1:S7-15. DOI: 10.1016/j.jcv.2004.12.006. View

Cooper C, Upmeyer S, Winokur P . Identification of single amino acids in the human papillomavirus 11 E2 protein critical for the transactivation or replication functions. Virology. 1998; 241(2):312-22. DOI: 10.1006/viro.1997.8941. View

Porter S, McBride A . Human Papillomavirus Quasivirus Production and Infection of Primary Human Keratinocytes. Curr Protoc Microbiol. 2020; 57(1):e101. PMC: 7263449. DOI: 10.1002/cpmc.101. View

Ingle A, Ghim S, Joh J, Chepkoech I, Jenson A, Sundberg J . Novel laboratory mouse papillomavirus (MusPV) infection. Vet Pathol. 2010; 48(2):500-5. DOI: 10.1177/0300985810377186. View

Prabhakar A, James C, Fontan C, Otoa R, Wang X, Bristol M . Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle. J Virol. 2023; 97(3):e0006323. PMC: 10062148. DOI: 10.1128/jvi.00063-23. View

Longo P, Kavran J, Kim M, Leahy D . Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol. 2013; 529:227-40. PMC: 4012321. DOI: 10.1016/B978-0-12-418687-3.00018-5. View

Handisurya A, Day P, Thompson C, Buck C, Pang Y, Lowy D . Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization. J Virol. 2013; 87(24):13214-25. PMC: 3838223. DOI: 10.1128/JVI.02162-13. View

10.

Zheng G, Schweiger M, Martinez-Noel G, Zheng L, Smith J, Harper J . Brd4 regulation of papillomavirus protein E2 stability. J Virol. 2009; 83(17):8683-92. PMC: 2738164. DOI: 10.1128/JVI.00674-09. View

11.

Fradet-Turcotte A, Morin G, Lehoux M, Bullock P, Archambault J . Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. Virology. 2010; 399(1):65-76. PMC: 3154085. DOI: 10.1016/j.virol.2009.12.026. View

12.

Rous P, BEARD J . A VIRUS-INDUCED MAMMALIAN GROWTH WITH THE CHARACTERS OF A TUMOR (THE SHOPE RABBIT PAPILLOMA) : I. THE GROWTH ON IMPLANTATION WITHIN FAVORABLE HOSTS. J Exp Med. 2009; 60(6):701-22. PMC: 2132413. DOI: 10.1084/jem.60.6.701. View

13.

Caron C, Boyault C, Khochbin S . Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability. Bioessays. 2005; 27(4):408-15. DOI: 10.1002/bies.20210. View

14.

Cladel N, Hu J, Balogh K, Mejia A, Christensen N . Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection. J Virol Methods. 2007; 148(1-2):34-9. PMC: 2278115. DOI: 10.1016/j.jviromet.2007.10.005. View

15.

Stubenrauch F, Straub E, Klein K, Kramer D, Iftner T, Wong M . EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO. J Virol. 2021; 95(8). PMC: 8103706. DOI: 10.1128/JVI.01930-20. View

16.

Sakai H, Yasugi T, Benson J, Dowhanick J, Howley P . Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J Virol. 1996; 70(3):1602-11. PMC: 189983. DOI: 10.1128/JVI.70.3.1602-1611.1996. View

17.

Zhou X, Zheng W, Li Y, Pearce R, Zhang C, Bell E . I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction. Nat Protoc. 2022; 17(10):2326-2353. DOI: 10.1038/s41596-022-00728-0. View

18.

Skiadopoulos M, McBride A . The bovine papillomavirus type 1 E2 transactivator and repressor proteins use different nuclear localization signals. J Virol. 1996; 70(2):1117-24. PMC: 189919. DOI: 10.1128/JVI.70.2.1117-1124.1996. View

19.

Kumar R, Naidu S, Wang X, Imbalzano A, Androphy E . Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation. J Virol. 2006; 81(5):2213-20. PMC: 1865958. DOI: 10.1128/JVI.01746-06. View

20.

Stranska R, Schuurman R, Nienhuis E, Goedegebuure I, Polman M, Weel J . Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol. 2004; 32(1):7-18. DOI: 10.1016/j.jcv.2004.04.002. View